Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

  

Search in our Online Store
DNA, RNA & Cells
Filter     Order     Display # 
Date Item Title
03 Jul 2008 VAVELTA(R) Phase II data presented at FACE
02 Jul 2008 Isolagen Completes Pivotal Efficacy Portion of Phase III Studies of Isolagen Therapy(TM) for Wrinkles
02 Jul 2008 Titan Pharmaceuticals Announces Spheramine(R) Initial Phase IIb Results
02 Jul 2008 MicroIslet Provides Safety and Efficacy Data Update
30 Jun 2008 Teva & ANP Announce That Atl/Tv1102, a Novel Drug for The Treatment Of Relapsing Remitting Multiple Sclerosis (Rrms), Demonstrated Significant Reduction In Disease Activity
30 Jun 2008 Introgen Submits ADVEXIN(R) Regulatory Applications in the U.S. and Europe
25 Jun 2008 Osiris Therapeutics Announces $2 Million Milestone Payment for Clinical Progress of a Stem Cell Therapy for Type 1 Diabetes
25 Jun 2008 FDA approves Quark IND for DGFi, an siRNA therapeutic based on Silence Therapeutics’ Unique Proprietary Chemistry
22 Jun 2008 Oncolytics Biotech Inc. Announces U.S. Phase 2 Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin
19 Jun 2008 Alnylam and Kyowa Hakko Form Alliance for the Development and Commercialization of ALN-RSV01 in Asia
18 Jun 2008 AVONTEC announces results of a multiple dose clinical phase I study with its drug candidate AVT-02 UE ointment after topical treatment in male healthy volunteers
17 Jun 2008 Aastrom to Initiate Phase II Clinical Trial Using Cardiac Repair Cells Derived From Patient's Own Bone Marrow for Treatment of Severe Chronic Heart Failure
16 Jun 2008 Opexa Therapeutics Presents Monocyte-Derived Islet Cell Research at the International Society for Stem Cell Research Annual Meeting
15 Jun 2008 AMT prepares for submission of Marketing Authorization Dossier for AMT-011 (Glybera(R))
12 Jun 2008 Targeted Genetics Announces Positive Phase 1/2 tgAAC94 Data Presented at Annual European Congress of Rheumatology
12 Jun 2008 NOXXON Pharma AG Announces Licensing and Discovery Collaboration with Eli Lilly and Company
10 Jun 2008 Isis Highlights Robust Drug Portfolio for Diabetes and Obesity at ADA Conference
09 Jun 2008 Gentium Announces Update from Data Safety Monitoring Board Review of the Phase III Treatment Trial of Defibrotide for Severe Veno-Occlusive Disease
08 Jun 2008 Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs
04 Jun 2008 Newly Published Study Shows OPKO's siRNA Bevasiranib Is Taken Up by Target Tissues in the Eye
04 Jun 2008 Nuvelo Initiates Phase 1B Clinical Trial of Anticoagulant NU172
03 Jun 2008 Isis' Partners Present Clinical Data on Antisense Drugs at the American Society of Clinical Oncology
03 Jun 2008 EMEA provides Guidance on Phase III Design and Approval Requirements
03 Jun 2008 Anti-TGF-beta Antisense AP 12009 shows very good Safety and Tolerability in Systemic Treatment of Pancreatic Carcinoma, Malignant Melanoma and Colorectal Carcinoma
03 Jun 2008 Oncogenex reports that low serum clusterin levels were predictive of survival in preliminary analyses of phase 2 study of lead drug candidate OGX-011
03 Jun 2008 Calando Pharmaceuticals Doses First Patient in siRNA Phase I Clinical Trial
02 Jun 2008 Biovex reports positive phase II clinical trial results of Oncovexgm-CSF in metastatic melanoma at the 2008 American Society of Clinical Oncology Meeting
30 May 2008 Targeted Genetics Reports Additional Data From Inflammatory Arthritis Clinical Trial
30 May 2008 Genasense(R) Chemotherapy Program Yields High Response Rate in Patients with Stage 4 Melanoma
30 May 2008 AMT Announces Positive Interim Clinical Data on its Lead Product AMT-011
30 May 2008 VIRxSYS Presents New VRX496 Phase II HIV Gene Therapy Trial Data
30 May 2008 BioAlliance Pharma Presents New Results on its AMEP(TM) anti-invasive biotherapy
29 May 2008 Phase I/II Study of Targeted Gene Delivery In Vivo - Intravenous Infusions of REXIN-G - Demonstrates Dose-Dependent Anti-Tumor Activity Without Toxicity in Patients With Progressive Chemo-Resistant Bone and Soft Tissue Sarcoma (ASCO 2008)
28 May 2008 ADVEXIN(R) Improves Survival in Recurrent, Refractory Head and Neck Cancer Patients
28 May 2008 Santaris Pharma begins human clinical testing of the world’s first medicine targeted at a human microRNA
27 May 2008 Alnylam and Takeda Form Strategic Worldwide Platform Alliance in RNAi TherapeuticsAlnylam and Takeda Form Strategic Worldwide Platform Alliance in RNAi Therapeutics
21 May 2008 Cell Genesys Reports Encouraging Interim Data From Phase 1 Clinical Trial of CG0070 in Recurrent Bladder Cancer
19 May 2008 Preclinical Data Demonstrate Ability to Regenerate an Entire Bladder with Tengion Neo-Bladder Replacement(TM)
16 May 2008 OncoGenex reports updated survival data on OGX-011 in a second-line chemotherapy trial for patients with prostate cancer
15 May 2008 FDA Places Geron’s GRNOPC1 IND on Clinical Hold
13 May 2008 AVI BioPharma Announces Significant Advance in the Potential Treatment of Ebola and Marburg Virus Infections
12 May 2008 Argos Therapeutics Initiates Phase 2 Proof-of-Concept Trial for its Arcelis(TM) Personalized Immunotherapy Platform in HIV
09 May 2008 Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Combination REOLYSIN(R)/Cyclophosphamide Trial
09 May 2008 Osiris and NuVasive Enter into Definitive Agreement for Osteocel(R)
08 May 2008 Osiris Receives Approval for Use of Prochymal(TM) Under FDA Expanded Access Treatment Program
07 May 2008 FDA and the Paul Ehrlich Institute (Germany) Approve Pluristem’s Regulatory Submissions in Support of a Phase I/II Clinical Trial Utilizing PLX-PAD for Peripheral Artery Disease
05 May 2008 MOLOGEN AG receives approval for clinical study with cancer drug MGN1703
02 May 2008 Celgene Cellular Therapeutics Announces Clinical Transplant of Human Placenta-Derived Stem Cells
30 Apr 2008 Topigen reports progess toward clinical trials for TPI 1100 at Rnai World CongressTopigen reports progess toward clinical trials for TPI 1100 at Rnai World Congress
29 Apr 2008 Nuvelo Announces Positive Proof-of-Concept Data With Anticogulant NU172
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 1 - 50 of 563

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Integrin Antagonists

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonistgs & Antagonists

Order Now

Subscribe La Merie Biologics